NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
This Quarter Return
+2.28%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.02B
AUM Growth
+$1.02B
(-12%)
Cap. Flow
-$141M
Cap. Flow
% of AUM
-13.8%
Top 10 Holdings %
Top 10 Hldgs %
46.08%
Holding
129
New
15
Increased
17
Reduced
59
Closed
17
Top Buys
| 1 |
Pathward Financial
CASH
|
$11.3M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$8.49M |
| 3 |
Costco
COST
|
$7.15M |
| 4 |
Ventyx Biosciences
VTYX
|
$4.07M |
| 5 |
IDEAYA Biosciences
IDYA
|
$3.78M |
Top Sells
| 1 |
Syndax Pharmaceuticals
SNDX
|
$30.9M |
| 2 |
Avalo Therapeutics
AVTX
|
$20.5M |
| 3 |
Light & Wonder
LNW
|
$17.8M |
| 4 |
Soleno Therapeutics
SLNO
|
$14.8M |
| 5 |
Semler Scientific
SMLR
|
$10.3M |
Sector Composition
| 1 | Healthcare | 43.43% |
| 2 | Consumer Discretionary | 19.31% |
| 3 | Industrials | 9.47% |
| 4 | Communication Services | 6.18% |
| 5 | Financials | 6.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
iShares Russell 2000 ETF
IWM
$67B
| $12.4M | 0.8% | 75,370 +51,497 | +216% | +$8.49M |
|
|
CNCE
27
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $12M | 0.77% | 1,787,159 +127,319 | +8% | +$853K |
|
28
Lyra Therapeutics
LYRA
$11.5M
| $11.3M | 0.73% | 2,245,830 -123,838 | -5% | -$620K |
|
|
AUTL
29
Autolus Therapeutics
AUTL
$399M
| $11.2M | 0.72% | 5,215,788 +72,933 | +1% | +$156K |
|
30
Viemed Healthcare
VMD
$286M
| $10.7M | 0.7% | 1,790,505 +75,579 | +4% | +$453K |
|
31
DarioHealth
DRIO
$22.8M
| $10.2M | 0.66% | 2,195,373 +464,563 | +27% | +$2.15M |
|
|
AMYT
32
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $9.95M | 0.64% | 1,437,458 -125,000 | -8% | -$865K |
|
33
Reading International Class A
RDI
$35M
| $9.6M | 0.62% | 2,916,575 -290,672 | -9% | -$956K |
|
|
CBAY
34
DELISTED
Cymabay Therapeutics
CBAY
| $8.66M | 0.56% | 2,474,659 -169,647 | -6% | -$594K |
|
|
ARYE
35
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
| $7.48M | 0.48% | 759,572 -102,994 | -12% | -$1.01M |
|
|
AKU
36
DELISTED
Akumin Inc. Common Stock (DE)
AKU
| $7.28M | 0.47% | 4,255,572 -1,289,661 | -23% | -$2.21M |
|
37
Fortress Biotech
FBIO
$76.8M
| $7.11M | 0.46% | 8,263,052 -495,596 | -6% | -$426K |
|
38
Aura Biosciences
AURA
$389M
| $6.95M | 0.45% | 383,764 +40,549 | +12% | +$735K |
|
39
RingCentral
RNG
$2.76B
| $6.7M | 0.43% | 167,622 +17,622 | +12% | +$704K |
|
40
ARS Pharmaceuticals
SPRY
$1.15B
| $6.6M | 0.43% | 1,249,863 -136,275 | -10% | -$720K |
|
41
ON24
ONTF
$242M
| $4.74M | 0.31% | 538,906 -31,497 | -6% | -$277K |
|
|
APTO
42
DELISTED
Aptose Biosciences, Inc.
APTO
| $4.1M | 0.27% | 6,888,822 -343,854 | -5% | -$205K |
|
|
43
Ventyx Biosciences
VTYX
$171M
| $4.07M | 0.26% | +116,633 | New | +$4.07M |
|
|
RDNW
44
RideNow Group, Inc. Class B Common Stock
RDNW
$147M
| $4.01M | 0.26% | 236,975 +36,975 | +18% | +$626K |
|
45
Strata Skin Sciences
SSKN
$9.93M
| $3.83M | 0.25% | 4,393,685 -182,127 | -4% | -$159K |
|
|
46
IDEAYA Biosciences
IDYA
$2.15B
| $3.78M | 0.24% | +253,480 | New | +$3.78M |
|
47
Taysha Gene Therapies
TSHA
$797M
| $3.25M | 0.21% | 1,610,822 -32,616 | -2% | -$65.7K |
|
48
Perella Weinberg Partners
PWP
$1.38B
| $3.2M | 0.21% | 505,293 +2,617 | +0.5% | +$16.6K |
|
49
B. Riley Financial
RILY
$168M
| $3.04M | 0.2% | 68,296 -8,787 | -11% | -$391K |
|
50
TELA Bio
TELA
$70.5M
| $2.97M | 0.19% | +349,002 | New | +$2.97M |
|